Serum DLAT Is a Potential Diagnostic Marker in AFP-Negative HCC

The aim of this study was to analyze dihydrolipoyllysine-residue acetyltransferase (DLAT) expression and diagnostic ability in hepatocellular carcinoma (HCC), assess its role in HCC growth, and factors affecting it. We conducted bioinformatics analyses, examined DLAT expression and prognosis in pre-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biological & pharmaceutical bulletin 2024-12, Vol.47 (12), p.2127-2137, Article b24-00516
Hauptverfasser:	Huang, Fangfang, Bai, Jindong, Hu, Limei, Luo, Changliang, Ning, Leping
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetyltransferases - blood Acetyltransferases - genetics alpha-Fetoproteins - metabolism Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - genetics Cell Line, Tumor DNA Methylation Female Gene Expression Regulation, Neoplastic Humans Liver Neoplasms - blood Liver Neoplasms - diagnosis Liver Neoplasms - genetics Male MicroRNAs - blood MicroRNAs - genetics Middle Aged
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!